{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:10:55Z","timestamp":1788351055798,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00894-014-2321-6","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T03:23:48Z","timestamp":1403580228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents"],"prefix":"10.1007","volume":"20","author":[{"given":"Lianjuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"2321_CR1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2008.03.011","volume":"26","author":"NH Mueller","year":"2008","unstructured":"Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA (2008) Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin 26:675\u2013697","journal-title":"Neurol Clin"},{"key":"2321_CR2","first-page":"9","volume":"9","author":"AM Watkins","year":"1998","unstructured":"Watkins AM, Dunford PJ, Moffatt AM, Wong-Kai-In P, Holland MJ, Pole DS, Thomas GM, Martin J, Roberts NA, Mulqueen MJ (1998) Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo. Antivir Chem Chemother 9:9\u201318","journal-title":"Antivir Chem Chemother"},{"key":"2321_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkf037","volume":"50","author":"J Balzarini","year":"2002","unstructured":"Balzarini J, McGuigan C (2002) Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication. J Antimicrob Chemother 50:5\u20139","journal-title":"J Antimicrob Chemother"},{"key":"2321_CR4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/368196","volume":"36","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH, Schmader KE (2003) Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 36:877\u2013882","journal-title":"Clin Infect Dis"},{"key":"2321_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.29.1.171","volume":"29","author":"AR Karlstr\u00f6m","year":"1986","unstructured":"Karlstr\u00f6m AR, K\u00e4llander CF, Abele G, Larsson A (1986) Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase. Antimicrob Agents Chemother 29:171\u2013174","journal-title":"Antimicrob Agents Chemother"},{"key":"2321_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3851\/IMP1762","volume":"21","author":"K Benci","year":"2011","unstructured":"Benci K, Suhina T, Mandi\u0107 L, Paveli\u0107 SK, Paravi\u0107 AT, Paveli\u0107 K, Balzarini J, Wittine K, Mintas M (2011) Novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: synthesis, antiviral and cytostatic activity evaluations. Antivir Chem Chemother 21:221\u2013230","journal-title":"Antivir Chem Chemother"},{"key":"2321_CR7","doi-asserted-by":"crossref","unstructured":"Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186:S3\u2013S28","DOI":"10.1086\/343739"},{"key":"2321_CR8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8","volume":"32","author":"JN Champness","year":"1998","unstructured":"Champness JN, Bennett MS, Wien F, Visse R, Summers WC, Herdewijn P, de Clerq E, Ostrowski T, Jarvest RL, Sanderson MR (1998) Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins 32:350\u2013361","journal-title":"Proteins"},{"key":"2321_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0925-4439(02)00091-1","volume":"1587","author":"J Balzarini","year":"2002","unstructured":"Balzarini J, McGuigan C (2002) Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides. Biochim Biophys Acta 1587:287\u2013295","journal-title":"Biochim Biophys Acta"},{"key":"2321_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/37.2.303","volume":"37","author":"TH Bacon","year":"1996","unstructured":"Bacon TH, Howard BA, Spender LC, Boyd MR (1996) Activity of penciclovir in antiviral assays against herpes simplex virus. J Antimicrob Chemother 37:303\u2013313","journal-title":"J Antimicrob Chemother"},{"key":"2321_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199856010-00012","volume":"56","author":"S Noble","year":"1998","unstructured":"Noble S, Faulds D (1998) Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 56:115\u2013146","journal-title":"Drugs"},{"key":"2321_CR12","unstructured":"O\u2019Brien JJ, Campoli-Richards DM (1989) Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37:233\u2013309"},{"key":"2321_CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(95)00900-0","volume":"30","author":"BM Gebhardt","year":"1996","unstructured":"Gebhardt BM, Wright GE, Xu H, Focher F, Spadari S, Kaufman HE (1996) 9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antivir Res 30:87\u201394","journal-title":"Antivir Res"},{"key":"2321_CR14","doi-asserted-by":"crossref","first-page":"32832","DOI":"10.1074\/jbc.M313343200","volume":"279","author":"P Schelling","year":"2004","unstructured":"Schelling P, Claus MT, Johner R, Marquez VE, Schulz GE, Scapozza L (2004) Biochemical and structural characterization of (south)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells. J Biol Chem 279:32832\u201332838","journal-title":"J Biol Chem"},{"key":"2321_CR15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.str.2003.09.003","volume":"11","author":"A Gardberg","year":"2003","unstructured":"Gardberg A, Shuvalova L, Monnerjahn C, Konrad M, Lavie A (2003) Structural basis for the dual thymidine and thymidylate kinase activity of herpes thymidine kinases. Structure 11:1265\u20131277","journal-title":"Structure"},{"key":"2321_CR16","doi-asserted-by":"crossref","unstructured":"Wurth C, Kessler U, Vogt J, Schulz GE, Folkers G, Scapozza L (2001) The effect of substrate binding on the conformation and structural stability of herpes simplex virus type 1 thymidine kinase. Protein Sci 10:63\u201373","DOI":"10.1110\/ps.27401"},{"key":"2321_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.31.3.368","volume":"31","author":"LM Nutter","year":"1987","unstructured":"Nutter LM, Grill SP, Dutschman GE, Sharma RA, Bobek M, Cheng YC (1987) Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus. Antimicrob Agents Chemother 31:368\u2013374","journal-title":"Antimicrob Agents Chemother"},{"key":"2321_CR18","doi-asserted-by":"crossref","unstructured":"Manikowski A, Verri A, Lossani A, Gebhardt BM, Gambino J, Focher F, Spadari S, Wright GE (2005) Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure\u2013activity relationships and antiherpetic activity in vivo. J Med Chem 48:3919\u20133929","DOI":"10.1021\/jm049059x"},{"key":"2321_CR19","doi-asserted-by":"crossref","unstructured":"Liu T, Lin Y, Wen X, Jorrisen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein\u2013ligand binding affinities. Nucleic Acids Res 35:D198\u2013D201","DOI":"10.1093\/nar\/gkl999"},{"key":"2321_CR20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/prot.20512","volume":"60","author":"L Hu","year":"2005","unstructured":"Hu L, Benson ML, Smith RD, Lerner MG, Carlson HA (2005) Binding MOAD (Mother Of All Databases). Proteins 60:333\u2013340","journal-title":"Proteins"},{"key":"2321_CR21","doi-asserted-by":"crossref","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242","DOI":"10.1093\/nar\/28.1.235"},{"key":"2321_CR22","doi-asserted-by":"crossref","unstructured":"Lu J, Zhang Z, Ni Z, Shen H, Tu Z, Liu H, Lu R, Shi H (2014) The non-additive contribution of hydroxyl substituents to Akt kinase\u2013apigenin affinity. Mol Simul (in press, DOI: 10.1080\/08927022.2014.913099 )","DOI":"10.1080\/08927022.2014.913099"},{"key":"2321_CR23","doi-asserted-by":"crossref","unstructured":"Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA\u2014a self-parameterizing force field. Proteins 47:393\u2013402","DOI":"10.1002\/prot.10104"},{"key":"2321_CR24","volume-title":"Gaussian 09","author":"MJ Frisch","year":"2009","unstructured":"Frisch MJ, Trucks GW, Schlegel HB et al (2009) Gaussian 09. Gaussian, Inc., Wallingford"},{"key":"2321_CR25","doi-asserted-by":"crossref","unstructured":"Svensson M, Humbe S, Froese RDJ, Matsubara T, Sieber S, Morokuma K (1996) ONIOM: a multilayered integrated MO + MM method for geometry optimizations and single point energy predictions. A test for Diels\u2013Alder reactions and Pt(P(t-Bu)3)2\u2009+\u2009H2 oxidative addition. J Phys Chem 100:19357\u201319363","DOI":"10.1021\/jp962071j"},{"key":"2321_CR26","doi-asserted-by":"crossref","unstructured":"Alzate-Morales JH, Caballero J, Vergara Jague A, Gonz\u00e1lez Nilo FD (2009) Insights into the structural basis of N2 and O6 substituted guanine derivatives as cyclin-dependent kinase 2 (CDK2) inhibitors: prediction of the binding modes and potency of the inhibitors by docking and ONIOM calculations. J Chem Inf Model 49:886\u2013899","DOI":"10.1021\/ci8004034"},{"key":"2321_CR27","doi-asserted-by":"crossref","unstructured":"Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP (1985) Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 107:3902\u20133909","DOI":"10.1021\/ja00299a024"},{"key":"2321_CR28","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1021\/ja00051a040","volume":"114","author":"AK Rappe","year":"1992","unstructured":"Rappe AK, Casewit CJ, Colwell KS, Goddard WA III, Skiff WM (1992) UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc 114:10024\u201310035","journal-title":"J Am Chem Soc"},{"key":"2321_CR29","doi-asserted-by":"crossref","unstructured":"Ni Z, Jin R, Chen H, Lin X (2013) Just an additional hydrogen bond can dramatically reduce the catalytic activity of Bacillus subtilis lipase A I12T mutant: An integration of computational modeling and experimental analysis. Comput Biol Med 43:1882\u20131888","DOI":"10.1016\/j.compbiomed.2013.08.018"},{"key":"2321_CR30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.comptc.2012.04.010","volume":"991","author":"X Guo","year":"2012","unstructured":"Guo X, He D, Liu L, Kuang R, Liu L (2012) Use of QM\/MM scheme to reproduce macromolecule\u2013small molecule noncovalent binding energy. Comput Theor Chem 991:134\u2013140","journal-title":"Comput Theor Chem"},{"key":"2321_CR31","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","volume":"38","author":"AD Becke","year":"1988","unstructured":"Becke AD (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38:3098\u20133100","journal-title":"Phys Rev A"},{"key":"2321_CR32","doi-asserted-by":"crossref","unstructured":"Lee C, Yang W, Parr RG (1988) Development of the Colle\u2013Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785\u2013789","DOI":"10.1103\/PhysRevB.37.785"},{"key":"2321_CR33","doi-asserted-by":"crossref","unstructured":"Zhou P, Zou J, Tian F, Shang Z (2009) Fluorine bonding\u2014how does it work in protein\u2013ligand interactions? J Chem Inf Model 49:2344\u20132355","DOI":"10.1021\/ci9002393"},{"key":"2321_CR34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889\u2013897","journal-title":"Acc Chem Res"},{"key":"2321_CR35","doi-asserted-by":"crossref","unstructured":"Rocchia W, Alexov W, Honig B (2001) Extending the applicability of the nonlinear Poisson\u2013Boltzmann equation: multiple dielectric constants and multivalent ions. J Phys Chem B 105:6507\u20136514","DOI":"10.1021\/jp010454y"},{"key":"2321_CR36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","volume":"38","author":"MF Sanner","year":"1996","unstructured":"Sanner MF, Olson AJ, Spehner JC (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38:305\u2013320","journal-title":"Biopolymers"},{"key":"2321_CR37","doi-asserted-by":"crossref","unstructured":"Amrhein I, Wurth C, Bohner T, Hofbauer R, Folkers G, Scapozza L (2000) Highly purified recombinant varicella zoster virus thymidine kinase is a homodimer. Protein Expr Purif 18:338\u2013345","DOI":"10.1006\/prep.2000.1201"},{"key":"2321_CR38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/prep.1994.1062","volume":"5","author":"J Fetzer","year":"1994","unstructured":"Fetzer J, Michael M, Bohner T, Hofbauer R, Folkers G (1994) A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase. Protein Expr Purif 5:432\u2013441","journal-title":"Protein Expr Purif"},{"key":"2321_CR39","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1021\/ja0365328","volume":"125","author":"U Ryde","year":"2003","unstructured":"Ryde U, Nilsson K (2003) Quantum chemistry can locally improve protein crystal structures. J Am Chem Soc 125:14232\u201314233","journal-title":"J Am Chem Soc"},{"key":"2321_CR40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1021\/ci800419j","volume":"49","author":"MP Gleeson","year":"2009","unstructured":"Gleeson MP, Gleeson D (2009) QM\/MM calculations in drug discovery: a useful method for studying binding phenomena? J Chem Inf Model 49:670\u2013677","journal-title":"J Chem Inf Model"},{"key":"2321_CR41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/092986712803414150","volume":"19","author":"P Zhou","year":"2012","unstructured":"Zhou P, Huang J, Tian F (2012) Specific noncovalent interactions at protein\u2013ligand interface: implications for rational drug design. Curr Med Chem 19:226\u2013238","journal-title":"Curr Med Chem"},{"key":"2321_CR42","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2174\/0929867311320150005","volume":"20","author":"P Zhou","year":"2013","unstructured":"Zhou P, Wang C, Ren Y, Yang C, Tian F (2013) Computational peptidology: a new and promising approach to therapeutic peptide design. Curr Med Chem 20:1985\u20131996","journal-title":"Curr Med Chem"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-014-2321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-014-2321-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-014-2321-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:55:10Z","timestamp":1559112910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-014-2321-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1007\/s00894-014-2321-6","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]},"article-number":"2321"}}